IL-6 Mediated Degeneration of Forebrain GABAergic Interneurons and Cognitive Impairment in Aged Mice through Activation of Neuronal NADPH Oxidase
Laura L. Dugan, Sameh S. Ali, Grigoriy Shekhtman et al. · PLoS ONE · 2009
Full textCC BY
Neurology
Filters3 filters applied
23 papersQuestions on this topic
Metabolomic Profiling in LRRK2-Related Parkinson's Disease
Krisztina K. Johansen, Lei Wang, Jan O. Aasly et al. · PLoS ONE · 2009
Full textCC BY
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
P F Ambros, I M Ambros, G M Brodeur et al. · British Journal of Cancer · 2009
Full textCC BY
α-Synuclein and neuronal cell death
Mark R Cookson · Molecular Neurodegeneration · 2009 · Review
Full textCC BY
Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin
David J. M. Lewis, Zhiming Huo, Susan Barnett et al. · PLoS ONE · 2009 · Case report
Full textCC BY
Muscle Mitochondrial Uncoupling Dismantles Neuromuscular Junction and Triggers Distal Degeneration of Motor Neurons
Luc Dupuis, Jose-Luis Gonzalez de Aguilar, Andoni Echaniz-Laguna et al. · PLoS ONE · 2009
Full textCC BY
Destabilizing Protein Polymorphisms in the Genetic Background Direct Phenotypic Expression of Mutant SOD1 Toxicity
Tali Gidalevitz, Thomas Krupinski, Susana Garcia et al. · PLoS Genetics · 2009
Full textCC BY
Neurofibromatosis type 2 (NF2): A clinical and molecular review
DGareth R Evans · Orphanet Journal of Rare Diseases · 2009 · Review
Full textCC BY
Transcranial magnetic stimulation, synaptic plasticity and network oscillations
Patricio T Huerta, Bruce T Volpe · Journal of NeuroEngineering and Rehabilitation · 2009 · Review
Full textCC BY
Dopamine Agonist Increases Risk Taking but Blunts Reward-Related Brain Activity
Jordi Riba, Ulrike M. Krämer, Marcus Heldmann et al. · PLoS ONE · 2008
Full textCC BY
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease
Melissa K McCoy, Malú G Tansey · Journal of Neuroinflammation · 2008 · Review
Full textCC BY
Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice
Bettina H Clausen, Kate L Lambertsen, Alicia A Babcock et al. · Journal of Neuroinflammation · 2008
Full textCC BY
Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier
Svetlana Stamatovic, Richard Keep, Anuska Andjelkovic · Current Neuropharmacology · 2008
Full textCC BY
Messenger RNA Oxidation Occurs Early in Disease Pathogenesis and Promotes Motor Neuron Degeneration in ALS
Yueming Chang, Qiongman Kong, Xiu Shan et al. · PLoS ONE · 2008
Full textCC BY
Resveratrol potently reduces prostaglandin E2production and free radical formation in lipopolysaccharide-activated primary rat microglia
Eduardo Candelario-Jalil, Antonio C Pinheiro de Oliveira, Sybille Gräf et al. · Journal of Neuroinflammation · 2007
Full textCC BY
Dynamic and redundant regulation of LRRK2 and LRRK1 expression
Saskia Biskup, Darren J Moore, Alexis Rea et al. · BMC Neuroscience · 2007
Full textCC BY
Paraneoplastic neurological syndromes
Jérôme Honnorat, Jean-Christophe Antoine · Orphanet Journal of Rare Diseases · 2007 · Review
Full textCC BY
Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra
Tom N Grammatopoulos, Susan M Jones, Ferogh A Ahmadi et al. · Molecular Neurodegeneration · 2007
Full textCC BY
A prospective study of neurofibromatosis type 1 cancer incidence in the UK
L Walker, D Thompson, D Easton et al. · British Journal of Cancer · 2006
Full textCC BY
Botulinum Neurotoxin Detection and Differentiation by Mass Spectrometry
John R. Barr, Hercules Moura, Anne E. Boyer et al. · Emerging Infectious Diseases · 2005
Full textCC BY